Literature DB >> 33511009

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity.

Zhi Zong1,2, Zhengkui Zhang3, Liming Wu1, Long Zhang1,2, Fangfang Zhou3.   

Abstract

Innate antiviral immunity is the first line of host defense against invading viral pathogens. Immunity activation primarily relies on the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs). Viral proteins or nucleic acids mainly engage three classes of PRRs: Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), and DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS). These receptors initiate a series of signaling cascades that lead to the production of proinflammatory cytokines and type I interferon (IFN-I) in response to viral infection. This system requires precise regulation to avoid aberrant activation. Emerging evidence has unveiled the crucial roles that the ubiquitin system, especially deubiquitinating enzymes (DUBs), play in controlling immune responses. In this review, an overview of the most current findings on the function of DUBs in the innate antiviral immune pathways is provided. Insights into the role of viral DUBs in counteracting host immune responses are also provided. Furthermore, the prospects and challenges of utilizing DUBs as therapeutic targets for infectious diseases are discussed.
© 2020 The Authors. Advanced Science published by Wiley‐VCH GmbH.

Entities:  

Keywords:  deubiquitinating enzymes; innate antiviral immunity; pattern recognition receptors; therapeutic approach

Year:  2020        PMID: 33511009      PMCID: PMC7816709          DOI: 10.1002/advs.202002484

Source DB:  PubMed          Journal:  Adv Sci (Weinh)        ISSN: 2198-3844            Impact factor:   16.806


  303 in total

Review 1.  Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.

Authors:  Diarmaid Hughes; Dan I Andersson
Journal:  Nat Rev Genet       Date:  2015-07-07       Impact factor: 53.242

2.  USP14 promotes K63-linked RIG-I deubiquitination and suppresses antiviral immune responses.

Authors:  Hongrui Li; Zizhao Zhao; Jing Ling; Linhui Pan; Xibao Zhao; Huihui Zhu; Juan Yu; Bin Xie; Jianzhong Shen; Weilin Chen
Journal:  Eur J Immunol       Date:  2018-11-28       Impact factor: 5.532

3.  MCPIP1 is a positive regulator of type I interferons antiviral activity.

Authors:  Liping Qian; Yibo Zuo; Wenjun Deng; Ying Miao; Jin Liu; Yukang Yuan; Tingting Guo; Liting Zhang; Jun Jin; Jun Wang; Hui Zheng
Journal:  Biochem Biophys Res Commun       Date:  2018-03-17       Impact factor: 3.575

4.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

5.  ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization.

Authors:  Wenxiang Sun; Yang Li; Lu Chen; Huihui Chen; Fuping You; Xiang Zhou; Yi Zhou; Zhonghe Zhai; Danying Chen; Zhengfan Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

6.  A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation.

Authors:  Keith Jarosinski; Lisa Kattenhorn; Benedikt Kaufer; Hidde Ploegh; Nikolaus Osterrieder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-04       Impact factor: 11.205

7.  Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization.

Authors:  Lina Herhaus; Ana B Perez-Oliva; Giorgio Cozza; Robert Gourlay; Simone Weidlich; David G Campbell; Lorenzo A Pinna; Gopal P Sapkota
Journal:  Sci Signal       Date:  2015-04-14       Impact factor: 8.192

8.  The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.

Authors:  Peyman Nakhaei; Thibault Mesplede; Mayra Solis; Qiang Sun; Tiejun Zhao; Long Yang; Tsung-Hsien Chuang; Carl F Ware; Rongtuan Lin; John Hiscott
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

9.  Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.

Authors:  Santhana G Devaraj; Nan Wang; Zhongbin Chen; Zihong Chen; Monica Tseng; Naina Barretto; Rongtuan Lin; Clarence J Peters; Chien-Te K Tseng; Susan C Baker; Kui Li
Journal:  J Biol Chem       Date:  2007-08-30       Impact factor: 5.157

10.  The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway.

Authors:  Lele Zhang; Ning Wei; Ye Cui; Ze Hong; Xing Liu; Qiang Wang; Senlin Li; Heng Liu; Huansha Yu; Yanni Cai; Quanyi Wang; Juanjuan Zhu; Wei Meng; Zhengjun Chen; Chen Wang
Journal:  PLoS Pathog       Date:  2018-11-02       Impact factor: 6.823

View more
  9 in total

Review 1.  Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity.

Authors:  Sijing Long; Li Yang; Wei Dang; Shuyu Xin; Mingjuan Jiang; Wentao Zhang; Jing Li; Yiwei Wang; Senmiao Zhang; Jianhong Lu
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

Review 2.  An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities.

Authors:  Guanghui Qian; Liyan Zhu; Gen Li; Ying Liu; Zimu Zhang; Jian Pan; Haitao Lv
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

3.  GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation.

Authors:  Qianjin Liu; Tianle Gu; Ling-Yan Su; Lijin Jiao; Xinhua Qiao; Min Xu; Ting Xie; Lu-Xiu Yang; Dandan Yu; Ling Xu; Chang Chen; Yong-Gang Yao
Journal:  Redox Biol       Date:  2021-10-18       Impact factor: 11.799

4.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07

5.  USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells.

Authors:  Ruitao Lu; Guangxian Wu; Meiling Chen; Dongmei Ji; Yonghong Liu; Grace Guoying Zhou; Wenmin Fu
Journal:  Mol Ther Oncolytics       Date:  2021-11-11       Impact factor: 7.200

Review 6.  Emerging Roles of lncRNAs Regulating RNA-Mediated Type-I Interferon Signaling Pathway.

Authors:  Xiaoxin Ji; Wei Meng; Zichuan Liu; Xin Mu
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

Review 7.  The RING finger protein family in health and disease.

Authors:  Chunmei Cai; Yan-Dong Tang; Jingbo Zhai; Chunfu Zheng
Journal:  Signal Transduct Target Ther       Date:  2022-08-30

8.  The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS.

Authors:  Tian-Chen Xiong; Ming-Cong Wei; Fang-Xu Li; Miao Shi; Hu Gan; Zhen Tang; Hong-Peng Dong; Tianzi Liuyu; Pu Gao; Bo Zhong; Zhi-Dong Zhang; Dandan Lin
Journal:  Nat Commun       Date:  2022-10-10       Impact factor: 17.694

Review 9.  Host Non-Coding RNA Regulates Influenza A Virus Replication.

Authors:  Yuejiao Liao; Shouqing Guo; Geng Liu; Zhenyu Qiu; Jiamin Wang; Di Yang; Xiaojing Tian; Ziling Qiao; Zhongren Ma; Zhenbin Liu
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.